ANNIE DIEN: Open Payments
NPI 1508406810 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 6 payments from 5 companies in 2025. Trend: 2023 $27 · 2024 $332 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $122 |
| Novo Nordisk Inc | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: EVENITY, NUCALA, ZEPBOUND, Wegovy.
Industry payments across CA — which companies pay providers there.
